Stay updated on Fostamatinib in COVID-19: Efficacy & Safety Clinical Trial
Sign up to get notified when there's something new on the Fostamatinib in COVID-19: Efficacy & Safety Clinical Trial page.

Latest updates to the Fostamatinib in COVID-19: Efficacy & Safety Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedNew study locations have been added across multiple US states and international sites (Argentina, Brazil, Mexico) and previous location entries have been removed; this update is labeled Revision: v3.3.3.SummaryDifference2%

- Check27 days agoNo Change Detected
- Check48 days agoChange DetectedPublication section wording updated to clarify that PubMed entries are automatically populated and may not all relate to the study, and a Revision: v3.3.2 tag was added.SummaryDifference0.1%

- Check56 days agoChange DetectedThe administrative notice about government funding and operating status was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check70 days agoChange DetectedNo significant changes detected in study details; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check99 days agoChange Detected- Added a government funding operating-status notice and updated operating details for NIH Clinical Center (high importance). - Updated version from v3.1.0 to v3.2.0 (moderate importance).SummaryDifference4%

- Check106 days agoChange DetectedUpdated to Revision: v3.1.0 and removed several drug-safety topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) while keeping the revision label as the primary addition.SummaryDifference0.4%

Stay in the know with updates to Fostamatinib in COVID-19: Efficacy & Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fostamatinib in COVID-19: Efficacy & Safety Clinical Trial page.